authors
- Dixon, Dave L
- Carbone, Salvatore
- Hayley Billingsley, PhD, RD, CEP
- Canada, Justin M
- Trankle, Cory R
- Kadariya, Dinesh
- Cooke, Richard
- Hart, Linda
- Van Tassell, Benjamin
- Abbate, Antonio
Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF Study.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2021
published in
has subject area
- Biomarkers
- Canagliflozin
- Cholesterol
- Cholesterol, HDL
- Cholesterol, LDL
- Diabetes Mellitus, Type 2
- Dipeptidyl-Peptidase IV Inhibitors
- Double-Blind Method
- Female
- Heart Failure, Systolic
- Humans
- Male
- Middle Aged
- Prospective Studies
- Sitagliptin Phosphate
- Sodium-Glucose Transporter 2 Inhibitors
- Time Factors
- Treatment Outcome